317 related articles for article (PubMed ID: 10964922)
1. c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines.
Brasher BB; Van Etten RA
J Biol Chem; 2000 Nov; 275(45):35631-7. PubMed ID: 10964922
[TBL] [Abstract][Full Text] [Related]
2. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
Van Etten RA; Debnath J; Zhou H; Casasnovas JM
Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
[TBL] [Abstract][Full Text] [Related]
3. Biochemical properties of the Cdc42-associated tyrosine kinase ACK1. Substrate specificity, authphosphorylation, and interaction with Hck.
Yokoyama N; Miller WT
J Biol Chem; 2003 Nov; 278(48):47713-23. PubMed ID: 14506255
[TBL] [Abstract][Full Text] [Related]
4. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
[TBL] [Abstract][Full Text] [Related]
5. Tyrosine phosphorylation in the SH3 domain disrupts negative regulatory interactions within the c-Abl kinase core.
Chen S; O'Reilly LP; Smithgall TE; Engen JR
J Mol Biol; 2008 Nov; 383(2):414-23. PubMed ID: 18775435
[TBL] [Abstract][Full Text] [Related]
6. Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain.
Duyster J; Baskaran R; Wang JY
Proc Natl Acad Sci U S A; 1995 Feb; 92(5):1555-9. PubMed ID: 7533294
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
8. Mutation of a phenylalanine conserved in SH3-containing tyrosine kinases activates the transforming ability of c-Abl.
Jackson PK; Paskind M; Baltimore D
Oncogene; 1993 Jul; 8(7):1943-56. PubMed ID: 8510937
[TBL] [Abstract][Full Text] [Related]
9. Evidence that SH2 domains promote processive phosphorylation by protein-tyrosine kinases.
Mayer BJ; Hirai H; Sakai R
Curr Biol; 1995 Mar; 5(3):296-305. PubMed ID: 7780740
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the catalytic activity of the Src family tyrosine kinase Hck by autophosphorylation at a novel site in the unique domain.
Johnson TM; Williamson NA; Scholz G; Jaworowski A; Wettenhall RE; Dunn AR; Cheng HC
J Biol Chem; 2000 Oct; 275(43):33353-64. PubMed ID: 10934191
[TBL] [Abstract][Full Text] [Related]
11. Crk family adaptor proteins trans-activate c-Abl kinase.
Shishido T; Akagi T; Chalmers A; Maeda M; Terada T; Georgescu MM; Hanafusa H
Genes Cells; 2001 May; 6(5):431-40. PubMed ID: 11380621
[TBL] [Abstract][Full Text] [Related]
12. Autophosphorylation induces autoactivation and a decrease in the Src homology 2 domain accessibility of the Lyn protein kinase.
Sotirellis N; Johnson TM; Hibbs ML; Stanley IJ; Stanley E; Dunn AR; Cheng HC
J Biol Chem; 1995 Dec; 270(50):29773-80. PubMed ID: 8530369
[TBL] [Abstract][Full Text] [Related]
13. Ligand regulates epidermal growth factor receptor kinase specificity: activation increases preference for GAB1 and SHC versus autophosphorylation sites.
Fan YX; Wong L; Deb TB; Johnson GR
J Biol Chem; 2004 Sep; 279(37):38143-50. PubMed ID: 15231819
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the human c-fes protein tyrosine kinase (p93c-fes) by its src homology 2 domain and major autophosphorylation site (Tyr-713).
Hjermstad SJ; Peters KL; Briggs SD; Glazer RI; Smithgall TE
Oncogene; 1993 Aug; 8(8):2283-92. PubMed ID: 7687763
[TBL] [Abstract][Full Text] [Related]
15. Direct analysis of the binding of the abl Src homology 2 domain to the activated epidermal growth factor receptor.
Zhu G; Decker SJ; Mayer BJ; Saltiel AR
J Biol Chem; 1993 Jan; 268(3):1775-9. PubMed ID: 7678409
[TBL] [Abstract][Full Text] [Related]
16. Domain interactions in protein tyrosine kinase Csk.
Sondhi D; Cole PA
Biochemistry; 1999 Aug; 38(34):11147-55. PubMed ID: 10460171
[TBL] [Abstract][Full Text] [Related]
17. Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain.
Xu B; Miller WT
Mol Cell Biochem; 1996 May; 158(1):57-63. PubMed ID: 8791285
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of RNA polymerase II carboxyl-terminal domain by the Abl-related gene product.
Baskaran R; Chiang GG; Mysliwiec T; Kruh GD; Wang JY
J Biol Chem; 1997 Jul; 272(30):18905-9. PubMed ID: 9228069
[TBL] [Abstract][Full Text] [Related]
19. Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop.
Roumiantsev S; Shah NP; Gorre ME; Nicoll J; Brasher BB; Sawyers CL; Van Etten RA
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10700-5. PubMed ID: 12149456
[TBL] [Abstract][Full Text] [Related]
20. An intramolecular SH3-domain interaction regulates c-Abl activity.
Barilá D; Superti-Furga G
Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
